These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 27570219

  • 1. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA, Wen J, Shum J, Doerner J, Herlitz L, Putterman C.
    Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
    [Abstract] [Full Text] [Related]

  • 2. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
    Mike EV, Makinde HM, Der E, Stock A, Gulinello M, Gadhvi GT, Winter DR, Cuda CM, Putterman C.
    Front Immunol; 2018 Dec; 9():2189. PubMed ID: 30319641
    [Abstract] [Full Text] [Related]

  • 3. Macrophage depletion ameliorates nephritis induced by pathogenic antibodies.
    Chalmers SA, Chitu V, Herlitz LC, Sahu R, Stanley ER, Putterman C.
    J Autoimmun; 2015 Feb; 57():42-52. PubMed ID: 25554644
    [Abstract] [Full Text] [Related]

  • 4. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
    Wen J, Xia Y, Stock A, Michaelson JS, Burkly LC, Gulinello M, Putterman C.
    J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
    [Abstract] [Full Text] [Related]

  • 5. CXCL13 Neutralization Attenuates Neuropsychiatric Manifestations in Lupus-Prone Mice.
    Huang MW, Stock AD, Putterman C.
    Front Immunol; 2021 Jun; 12():763065. PubMed ID: 34868008
    [Abstract] [Full Text] [Related]

  • 6. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.
    Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
    [Abstract] [Full Text] [Related]

  • 7. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM, Stanley ER, Kelley VR.
    J Immunol; 2004 Oct 01; 173(7):4744-54. PubMed ID: 15383612
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L, Hu J, Chen L, Zhang Y, Wang Q, Yang X.
    Front Immunol; 2021 Oct 01; 12():584414. PubMed ID: 33717066
    [Abstract] [Full Text] [Related]

  • 9. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 10. Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
    Nocito C, Lubinsky C, Hand M, Khan S, Patel T, Seliga A, Winfield M, Zuluaga-Ramirez V, Fernandes N, Shi X, Unterwald EM, Persidsky Y, Sriram U.
    Front Immunol; 2020 Sep 15; 11():573677. PubMed ID: 33042154
    [Abstract] [Full Text] [Related]

  • 11. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.
    Ji J, Xu J, Li F, Li X, Gong W, Song Y, Dou H, Hou Y.
    Acta Biochim Biophys Sin (Shanghai); 2016 May 15; 48(5):411-9. PubMed ID: 27121231
    [Abstract] [Full Text] [Related]

  • 12. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
    Keil A, Hall SR, Körner M, Herrmann M, Schmid RA, Frese S.
    Arthritis Res Ther; 2016 Oct 22; 18(1):243. PubMed ID: 27770825
    [Abstract] [Full Text] [Related]

  • 13. Lipocalin-2 drives neuropsychiatric and cutaneous disease in MRL/lpr mice.
    Garcia SJ, Mike EV, Zhang J, Cuda CM, Putterman C.
    Front Immunol; 2024 Oct 22; 15():1466868. PubMed ID: 39399497
    [Abstract] [Full Text] [Related]

  • 14. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.
    Zhang LY, Li H, Wu YW, Cheng L, Yan YX, Yang XQ, Zhu FH, He SJ, Tang W, Zuo JP.
    Am J Physiol Renal Physiol; 2017 Apr 01; 312(4):F769-F777. PubMed ID: 28100505
    [Abstract] [Full Text] [Related]

  • 15. Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.
    Chalmers SA, Wen J, Doerner J, Stock A, Cuda CM, Makinde HM, Perlman H, Bosanac T, Webb D, Nabozny G, Fine JS, Klein E, Ramanujam M, Putterman C.
    Arthritis Res Ther; 2018 Jan 25; 20(1):10. PubMed ID: 29370834
    [Abstract] [Full Text] [Related]

  • 16. Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice.
    Iwata Y, Boström EA, Menke J, Rabacal WA, Morel L, Wada T, Kelley VR.
    J Immunol; 2012 May 01; 188(9):4568-80. PubMed ID: 22467656
    [Abstract] [Full Text] [Related]

  • 17. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, Kakimoto T, Utsumi H, Oshita K, Kataoka H.
    J Immunol Res; 2019 May 01; 2019():5821589. PubMed ID: 31930150
    [Abstract] [Full Text] [Related]

  • 18. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
    Schwarting A, Moore K, Wada T, Tesch G, Yoon HJ, Kelley VR.
    J Immunol; 1998 Apr 15; 160(8):4074-81. PubMed ID: 9558118
    [Abstract] [Full Text] [Related]

  • 19. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
    Lu LD, Stump KL, Wallace NH, Dobrzanski P, Serdikoff C, Gingrich DE, Dugan BJ, Angeles TS, Albom MS, Mason JL, Ator MA, Dorsey BD, Ruggeri BA, Seavey MM.
    J Immunol; 2011 Oct 01; 187(7):3840-53. PubMed ID: 21880982
    [Abstract] [Full Text] [Related]

  • 20. Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis.
    Menke J, Rabacal WA, Byrne KT, Iwata Y, Schwartz MM, Stanley ER, Schwarting A, Kelley VR.
    J Am Soc Nephrol; 2009 Dec 01; 20(12):2581-92. PubMed ID: 19926892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.